Properties
What is it?
Yuvit D3 Composition: The active substance of the preparation is cholecalciferol, in an amount of 0.5 mg (20,000 IU) per 1 ml (1 ml corresponds to 34 drops). Excipients: triglycerides of saturated fatty acids with medium chain length (Miglyol 821). Pharmacotherapeutic group: Vitamin. Indications: Recommendations for the use of the preparation: Prevention of rickets in children, prevention of symptoms in case of vitamin D deficiency. Treatment of rickets and osteomalacia caused by vitamin D deficiency. Dosage and administration: For oral administration. Preventive use: Newborns from two weeks to one year of age: 1 drop per day (590 IU (International Units)); Premature infants, twins, and newborns in poor living conditions: 1 to 2 drops per day (590 IU (International Units) - 1180 IU (International Units)). Children aged two years (especially during autumn and winter periods): 1 to 2 drops per day (590 IU (International Units) - 1180 IU (International Units)); Adults: 1 to 2 drops per day (590 IU (International Units) - 1180 IU (International Units)). For treatment: Rickets and osteomalacia caused by vitamin D deficiency: 2 to 8 drops per day (1180 IU (International Units) - 4720 IU (International Units)), throughout the year. For newborns and young children, the preparation should be administered via a spoon filled with drink or food. As there is a risk of overdose, the patient should not drink the preparation directly from the bottle. A double dose should not be taken to compensate for a missed dose. Side effects: Taking large doses of vitamin D3 causes hypervitaminosis and hypercalcemia, as well as associated symptoms: damage to the heart muscle. Headache. Loss of appetite, nausea, vomiting, diarrhea. Muscle and joint pain. Ecopolar calcification, dry sensation in the oral cavity. Contraindications: Allergy to the active substance of the preparation or any other component of this preparation; if the patient has: hypercalcemia, kidney stones, sarcoidosis, lack of hydroxylase activity of cholecalciferol in the liver and kidneys. Interactions with other drugs: It is necessary to inform the doctor or pharmacist about all medications currently or previously taken, even those intended to be taken. Simultaneous use of the preparation with some diuretics (e.g., chlorothiazide) increases the risk of hypercalcemia. When taking calcium preparations simultaneously, serum calcium levels should be monitored. Antiepileptic drugs (e.g., carbamazepine, phenobarbital, phenytoin, and primidone) may increase the requirement for vitamin D3. Cholestyramine, colestipol, or neomycin may reduce the absorption of vitamin D3. Simultaneous intake of vitamin D3 and cardiac glycosides may enhance the toxic effects of the preparation (increased risk of cardiac rhythm disturbances). Glucocorticosteroids may weaken the effect of vitamin D3. Special instructions: If the patient takes Yuvit D3 with other preparations or food products containing vitamin D, it may lead to overdose. With long-term use of vitamin D3 or doses exceeding 1000 IU (International Units), it is necessary to monitor serum calcium levels. Taking Yuvit D3 with food and drink is allowed. Pregnancy and lactation: If the patient is pregnant or breastfeeding, or suspects she is pregnant or plans to have a baby, she should consult a doctor or pharmacist before taking the preparation. The use of the preparation during pregnancy is possible only in cases of urgent necessity. Vitamins D3 and its metabolites pass into breast milk. No overdose has been reported in infants fed with breast milk.